News

Opinion
miasdigitaldiary on MSN24mOpinion
Can’t Stop Making Stickers with Microsoft Designer
‘I disagree’: Chicago Cubs manager calls out ump after 6-1 loss to Boston Inside US Dry Dock Rolling Out & Launching Gigantic Aircraft Carrier After Repair Tom Troupe, Stage and Screen Actor Who ...
Brandon Woyshnis on MSN26mOpinion
Be in My New Video – Griot’s Tacoma Event!
WNBA stars' All-Star Game message on pay increase draws social media reaction Ukrainian drones attack Moscow as Zelenskyy ...
Economic development drives higher obesity rates worldwide, but not because people move less. Instead, rising consumption of ...
LAHORE: Pakistan is facing a full-blown obesity epidemic, with 81% of women and 74% of men now classified as obese, health ...
Novo Nordisk's recent financial results and clinical progress haven't impressed Wall Street. Investors looking to strike ...
More than 40% of Americans are obese, according to the Centers for Disease Control and Prevention (CDC). And the epidemic isn ...
Researchers analyzed national health data from 2008 to 2023, uncovering a surge in the most severe obesity categories for children aged 2 to 18 years old.
Public health experts on Community Giants panel expose the critical link between food insecurity and preventable health ...
A new study has found that older adults and women taking the weight-loss drug semaglutide may lose more muscle than others, ...
GLP-1 receptor agonists semaglutide and tirzepatide are associated with reduced risks of dementia, stroke, and mortality in adults with type 2 diabetes and obesity, new data show.
Some health experts view GLP-1s as a promising option for PCOS, which lacks a standard treatment and affects millions of ...
Novo Nordisk sees solid Q1 results, major GLP-1 growth potential, and limited downside despite guidance cut and rising risks.